Gentium SpA (fka GENTY)

[surf1944]

7:03AM Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 (GENT) 11.59 : Co announced that it has been informed that the Company's Marketing Authorization Application for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing haematopoietic stem cell transplantation therapy will be on the agenda for discussion at the European Medicines Agency's Committee for Medicinal Products for Human Use meetings scheduled to be held on February 18-21, 2013.